Centre for Translational Research and Training on Endocrine Pancreas and Type 2 Diabetes in India
Funding Agency: DBT Wellcome Trust India Alliance
Duration: 2024–2029

Development of biomimetic natural proteinaceous device for effective islet cell transplantation to treat patients with diabetes
Funding Agency: SERB-DST
Duration: 2022–2025

A cross-sectional study of prevalence and risk factors for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis (NAFLD/NASH) among information technology (IT) employees working in Hyderabad
Funding Agency: IoE, University of Hyderabad
Duration: 2021–2024

Understanding the regulatory role of co-activator binding protein PIMT in the pancreatic β-cells of diabetic animals and T3C diabetic humans
Funding Agency: SERB-DST
Duration: 2021–2024

Whole exome sequencing to identify functionally relevant variants that confer higher susceptibility of hepatic fatty infiltration in the Indian ethnicity
Funding Agency: ICMR
Duration: 2021–2024

Proteomic analysis of pancreatic protein plugs in pursuit to identify pathways that lead to ductal obstruction in chronic pancreatitis
Funding Agency: ICMR
Duration: 2020–2024

Association of altered gut microbiome (fungome) and fungal metabolites with disease phenotype in patients with chronic pancreatitis
Funding Agency: SERB-DST
Duration: 2020–2024

Plasma metabolomic profiling to identify metabolic biomarkers for early detection of prediabetes associated with pancreatogenic diabetes (Type 3cDM) in chronic pancreatitis
Funding Agency: SERB-DST
Duration: 2020–2023

Molecular characterization of the functional role of ser/thr phosphatase PHLPP in pancreatic β-cells to gain mechanistic insights into diabetes
Funding Agency: SERB-DST
Duration: 2020–2023

A global gene expression-based approach to identify a panel predictive of recurrence risk in colorectal cancer of Indian ethnicity
Funding Agency: ICMR
Duration: 2019–2022

Role of gut microbial dysbiosis and metabolomic alterations in chronic pancreatitis and associated metabolic abnormalities
Funding Agency: DBT Wellcome Trust
Duration: 2018–2023

Development of macro-encapsulation device for islet cell transplantation for diabetes treatment
Funding Agency: IMPRINT Scheme
Duration: 2017–2020

Nutraceutical and protective influence of epigallocatechin gallate (EGCG) on islet functions in chronic pancreatitis – a proof-of-concept study in rodents
Funding Agency: ICMR
Duration: 2017–2019

Studies on pathogenesis of human acute pancreatitis
Funding Agency: DBT Wellcome Trust
Duration: 2012–2017

Impact of genetic polymorphisms of CYP2C19 and CYP3A4 on the pharmacokinetics and pharmacodynamics of proton pump inhibitors in Andhra Pradesh population (Telugu origin)
Funding Agency: ICMR
Duration: 2012–2015

Studies on intestinal microbiota of ethnically diverse tribal populations of India: enhancing understanding of the effect of host genotype, diet and ecology
Funding Agency: DBT
Duration: 2011–2014

Study of the growth inhibitory efficacy of celecoxib in combination with antibiotics on clinically isolated bacterial strains and in a mouse model of sepsis
Funding Agency: ICMR
Duration: 2012–2013

MicroRNA profiling in periampullary carcinoma in Indian population
Funding Agency: DBT
Duration: 2011–2013

Genetic analysis of gallstone disease in Indian population
Funding Agency: DBT
Duration: 2010–2013

Functional and gene expression studies in islets during progression of chronic pancreatitis
Funding Agency: ICMR
Duration: 2010–2013

Functional assessment of adult human pancreatic islets following autologous transplantation
Funding Agency: DBT
Duration: 2010–2012